Brief: Cabaletta Bio reports Q2 results
11/08/2022 12:03
Aug 11 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* QTRLY NET LOSS PER SHARE BASIC AND DILUTED $0.45
* Q2 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6pvn2w
Further company coverage: CABA.O
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity